RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.8981
-0.0092 (-1.01%)
At close: Jul 29, 2026, 4:00 PM EDT
0.8900
-0.0081 (-0.90%)
After-hours: Jul 29, 2026, 5:16 PM EDT
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $40.5 million as of July 29, 2026. Its market cap has decreased by -11.40% in one year.
Market Cap
40.50M
Enterprise Value
29.54M
1-Year Change
-11.40%
Ranking
Category
Stock Price
$0.90
ChartMarket Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $40.50M, a decrease of -40.99%. That is a compound annual growth rate of -10.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 40.50M | 31.55% |
| Dec 31, 2025 | 30.79M | -0.56% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | 68.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seres Therapeutics | 46.48M |
| INmune Bio | 45.99M |
| Metagenomi Therapeutics | 45.18M |
| Edesa Biotech | 43.66M |
| Filana Therapeutics | 43.18M |
| Radiopharm Theranostics | 41.12M |
| Dyadic International | 40.55M |
| Apollomics | 40.01M |